Catalyst Pharmaceuticals Inc (CPRX)
15.18
+0.14
(+0.90%)
USD |
NASDAQ |
May 01, 16:00
15.18
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Max Drawdown (5Y): 64.87% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 64.87% |
March 31, 2024 | 64.87% |
February 29, 2024 | 64.87% |
January 31, 2024 | 64.87% |
December 31, 2023 | 64.87% |
November 30, 2023 | 64.87% |
October 31, 2023 | 64.87% |
September 30, 2023 | 66.55% |
August 31, 2023 | 66.55% |
July 31, 2023 | 66.55% |
June 30, 2023 | 66.55% |
May 31, 2023 | 66.55% |
April 30, 2023 | 66.55% |
March 31, 2023 | 66.55% |
February 28, 2023 | 66.55% |
January 31, 2023 | 66.55% |
December 31, 2022 | 66.55% |
November 30, 2022 | 66.55% |
October 31, 2022 | 66.55% |
September 30, 2022 | 66.55% |
August 31, 2022 | 66.55% |
July 31, 2022 | 66.55% |
June 30, 2022 | 66.55% |
May 31, 2022 | 66.55% |
April 30, 2022 | 66.55% |
Date | Value |
---|---|
March 31, 2022 | 66.55% |
February 28, 2022 | 70.56% |
January 31, 2022 | 71.43% |
December 31, 2021 | 80.66% |
November 30, 2021 | 80.84% |
October 31, 2021 | 81.01% |
September 30, 2021 | 82.23% |
August 31, 2021 | 83.28% |
July 31, 2021 | 83.28% |
June 30, 2021 | 83.45% |
May 31, 2021 | 87.28% |
April 30, 2021 | 87.46% |
March 31, 2021 | 89.36% |
February 28, 2021 | 90.33% |
January 31, 2021 | 90.33% |
December 31, 2020 | 90.33% |
November 30, 2020 | 90.33% |
October 31, 2020 | 90.33% |
September 30, 2020 | 90.33% |
August 31, 2020 | 90.33% |
July 31, 2020 | 90.33% |
June 30, 2020 | 90.33% |
May 31, 2020 | 90.33% |
April 30, 2020 | 90.33% |
March 31, 2020 | 90.33% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
64.87%
Minimum
Oct 2023
90.33%
Maximum
May 2019
78.11%
Average
80.92%
Median
Max Drawdown (5Y) Benchmarks
Pfizer Inc | 54.78% |
Sarepta Therapeutics Inc | 64.93% |
PTC Therapeutics Inc | 73.78% |
Corcept Therapeutics Inc | 60.35% |
Cytokinetics Inc | 53.24% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 9.287 |
Beta (5Y) | 0.8908 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 61.42% |
Historical Sharpe Ratio (5Y) | 0.3128 |
Historical Sortino (5Y) | 0.6027 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.36% |